This has not been a great year for Denmark's Novo Nordisk (<a href="http://www.fiercepharma.com/tags/novo-nordisk">$NVO</a>) so far–the diabetes drugmaker failed to post double-digit sales growth in first quarter for the first time in four years. But the company believes its 2014 performance is just a temporary blip.
written on 25.06.2014
Novo Nordisk exec: We'll double sales within 10 years
